These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15121323)

  • 1. A global perspective on vaccine safety.
    Duclos P
    Vaccine; 2004 May; 22(15-16):2059-63. PubMed ID: 15121323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunisation safety: a priority of the World Health Organization's Department of Vaccines and Biologicals.
    Duclos P; Hofmann CA
    Drug Saf; 2001; 24(15):1105-12. PubMed ID: 11772144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization safety priority project at the World Health Organization.
    Duclos P; Delo A; Aguado T; Bilous J; Birmingham M; Kieny MP; Milstien J; Wood D; Tarantola D
    Semin Pediatr Infect Dis; 2003 Jul; 14(3):233-9. PubMed ID: 12913836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.
    ;
    Expert Rev Vaccines; 2009 Jun; 8(6):705-16. PubMed ID: 19485752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capacity for a global vaccine safety system: the perspective of national regulatory authorities.
    Graham JE; Borda-Rodriguez A; Huzair F; Zinck E
    Vaccine; 2012 Jul; 30(33):4953-9. PubMed ID: 22658930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety monitoring in vaccine development and immunization.
    Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
    Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The WHO Global Programme for Vaccines and Immunization Vaccine Trial Registry.
    Robertson SE; Mayans MV; Horsfall S; Wright PF; Clemens J; Ivanoff B; Lambert PH
    Bull World Health Organ; 1997; 75(4):295-305. PubMed ID: 9342888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Global immunization policies and recommendations: objectives and process].
    Duclos P; Okwo-Bele JM
    Med Sci (Paris); 2007 Apr; 23(4):409-16. PubMed ID: 17433232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee.
    Peter G; des Vignes-Kendrick M; Eickhoff TC; Fine A; Galvin V; Levine MM; Maldonado YA; Marcuse EK; Monath TP; Osborn JE; Plotkin S; Poland GA; Quinlisk MP; Smith DR; Sokol M; Soland DB; Whitley-Williams PN; Williamson DE; Breiman RF
    Pediatrics; 1999 Oct; 104(4 Pt 1):942-50. PubMed ID: 10506239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination vaccines: postlicensure safety evaluation.
    Chen RT; Pool V; Takahashi H; Weniger BG; Patel B
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S327-33. PubMed ID: 11709768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New challenges in assuring vaccine quality.
    Dellepiane N; Griffiths E; Milstien JB
    Bull World Health Organ; 2000; 78(2):155-62. PubMed ID: 10743279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization.
    Amarasinghe A; Black S; Bonhoeffer J; Carvalho SM; Dodoo A; Eskola J; Larson H; Shin S; Olsson S; Balakrishnan MR; Bellah A; Lambach P; Maure C; Wood D; Zuber P; Akanmori B; Bravo P; Pombo M; Langar H; Pfeifer D; Guichard S; Diorditsa S; Hossain MS; Sato Y
    Vaccine; 2013 Apr; 31 Suppl 2():B108-14. PubMed ID: 23598471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability evaluation of vaccines: WHO approach.
    Knezevic I
    Biologicals; 2009 Nov; 37(6):357-9; discussion 421-3. PubMed ID: 19729320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parental vaccine safety concerns: results from the National Immunization Survey, 2001-2002.
    Allred NJ; Shaw KM; Santibanez TA; Rickert DL; Santoli JM
    Am J Prev Med; 2005 Feb; 28(2):221-4. PubMed ID: 15710279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies.
    Chen RT
    Vaccine; 2004 May; 22(15-16):2047-53. PubMed ID: 15121321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of immunization injections in Africa: not simply a problem of logistics.
    Dicko M; Oni AQ; Ganivet S; Kone S; Pierre L; Jacquet B
    Bull World Health Organ; 2000; 78(2):163-9. PubMed ID: 10743280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chapter 22: Assuring the quality, safety and efficacy of HPV vaccines: the scientific basis of regulatory expectations pre- and post-licensure.
    Wood D; Shin JH; Duval B; Schmitt HJ
    Vaccine; 2006 Aug; 24 Suppl 3():S3/187-92. PubMed ID: 16950006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technologies that make administration of vaccines safer.
    Clements CJ; Larsen G; Jodar L
    Vaccine; 2004 May; 22(15-16):2054-8. PubMed ID: 15121322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ensuring vaccine safety in immunization programmes--a WHO perspective.
    Jodar L; Duclos P; Milstien JB; Griffiths E; Aguado MT; Clements CJ
    Vaccine; 2001 Feb; 19(13-14):1594-605. PubMed ID: 11166881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.
    Bines JE; Patel M; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S282-90. PubMed ID: 19817611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.